Sun Sep 29 00:07:06 UTC 2024: ## Scientech Research LLC Sells Off Eli Lilly & Company Shares

**New York, NY** – Scientech Research LLC has reduced its stake in Eli Lilly and Company (LLY) by a significant 53.1% during the second quarter, according to HoldingsChannel.com. The fund now owns 1,182 shares of the company, valued at $1,070,000. This move comes amidst a flurry of activity from other institutional investors and hedge funds, some of whom have acquired new positions in Lilly.

Capital Planning LLC, CHURCHILL MANAGEMENT Corp, M&G Plc, HighPoint Advisor Group LLC, and Leo Wealth LLC all bought new stakes in Lilly during the first and fourth quarters. Institutional investors now hold 82.53% of Lilly’s stock.

In other Lilly news, major shareholder Lilly Endowment Inc sold 8,848 shares of the company’s stock on July 3rd, for a total value of $8,098,662.88. This transaction was disclosed in a filing with the Securities & Exchange Commission. Over the past three months, insiders have sold a total of 423,559 shares worth $393,136,808.

Lilly shares opened at $877.50 on Friday, with the company boasting a market cap of $833.98 billion. The firm recently reported earnings data for the quarter ending August 8th, exceeding analyst estimates with $3.92 EPS, compared to a projected $2.64.

Analysts are forecasting that Eli Lilly and Company will post 16.49 EPS for the current fiscal year. The company continues to discover, develop, and market human pharmaceuticals worldwide, with notable products including insulin and diabetes medications.

For more information on Lilly and its holdings, visit HoldingsChannel.com.

Read More